Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

This study has been completed.
Sponsor:
Collaborators:
Alkermes, Inc.
New York City Department of Health and Mental Hygiene
Information provided by (Responsible Party):
Joshua D. Lee, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01180647
First received: August 10, 2010
Last updated: July 22, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)